Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1
J. Leandro, S. Khamrui, C. Suebsuwong, P.-J. Chen, C. Secor, T. Dodatko, C. Yu, R. Sanchez, R. DeVita, S. Houten, M. Lazarus
The paper characterizes the human LOR domain of AASS, presents its crystal structure, and identifies it as a potential drug target for glutaric aciduria type 1.
bioRxiv · May 20, 2022Biochemistry